BiotechTube
Home/Clevexel Pharma/Stéphane Dreyer
SD

Stéphane Dreyer

Board Member

Clevexel Pharma

Therapeutic Areas

Oncology Supportive CareImmuno-inflammatory Diseases

Clevexel Pharma Pipeline

DrugIndicationPhase
CVXL-0095Reduction of mucositis or dermatitis induced by radiotherapy or chemotherapyPre-clinical / Phase 1
CVXL-0255Immuno-inflammatory diseases (via inhibition of SYK and JAK enzymes)Pre-clinical

Leadership Team at Clevexel Pharma

CB
Christian Bloy
CEO, Co-founder, and Board Member
AB
Antoine Béjui
Board Member
ML
Marc Le Bozec
Board Member
SM
Stanislas-Léonard Malmezat
Board Member
View full Clevexel Pharma profile